Histamine-releasing factors

Current Opinion in Immunology

Volumn 8, Issue 6, 1996, Pages 778-783

  MacDonald, Susan M ^a  

^a JOHNS HOPKINS ASTHMA AND ALLERGY CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE;

ALLERGIC ASTHMA; BASOPHIL; HISTAMINE RELEASE; INFLAMMATION; MOLECULAR CLONING; SHORT SURVEY;

EID: 0030457527     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(96)80004-5     Document Type: Article

References (34)

1. MacDonald SM: Histamine releasing factors and IgE heterogeneity. In Allergy: Principles and Practice, edn 4. Edited by Middleton E, Reed CE, Ellis EF, Adkinson NF, Yunginger JW, Busse WW. St. Louis, Missouri: Mosby-Year Book Incorporated; 1993:1-11.
2. Maruyama N, Tamura G, Aizawa T, Ohrui T, Shimura S, Shirato K, Takishima T: Accumulation of basophils and their chemotaetic activity in the airways during natural airway narrowing in asthmatic individuals. Am J Respir Crit Care Med 1994, 150:1086-1093.
3. Koshino T, Arai Y, Miyamoto Y, Sano Y, Takaishi, T, Hirai K, Ito K, Monta Y: Mast cell and basophil number in the airway correlate with the bronchial responsiveness of asthmatics. Int Arch Allergy Immunol 1995, 107:378-379.
4. Thueson DO, Speck LS, Lett-Brown MA, Grant JA: Histamine releasing activity (HRA). I. Production by mitogen- or antigenstimulated human mononuclear cells. J Immunol 1979, 123:626-631.
5. Hedrick JA, Zlotnik A: Chemokines and lymphocyte biology. Curr Opin Immunol 1996, 8:343-347.
6. Kennedy J, Keiner GS, Kleyensteuber S, Schall TJ, Weiss MC, Yssel H, Schneider PV. Cocks BG, Bacon KB, Zlotnik A: Molecular cloning and functional characterization of human lymphotactin. J Immunol 1995, 155:203-209.
7. Weber M, Dahinden CA: Basophil and eosinophil activation by CC chemokines. Int Arch Allergy Immunol 1995, 107:148-150.
8. Ugucciorii M, Loetscher P, Forssmann U, Dewald, B, Li H, Lima SH, Li Y, Kreider B, Garotta G, Thelen M, Baggiolirii M: Monocyte chemotactic protein 4 (MCP-4), a novel structure and functional analogue of MCP-3 and eotaxin. J Exp Med 1998, 183:2379-2384.
9. Jose PJ, Griffiths-Johnson DA, Collins PD, Walsh DT, Moqbel R, Totty NF, Truong O, Hsuan JJ, Williams TJ : Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation. J Exp Med 1994, 179:861-887.
10. Stellato C. Beck L, Schwaben L, Li H, White J, Schleimer RP: A novel C-C chemokine, CKβ10 is expressed in airway epithelial cells and is a potent eosinophil chemoattractant. J Allergy Clin Immunol Abstr 1996, 97:304.
11. Weber M, Uguccioni M, Ochensberger B, Baggiolini M, Clark-Lewis I, Dahinden CA: Monocyte chemolactic protein MCP-2 activates human basophil and eosinophil leukocytes similar to MCP-3. J Immunol 1995, 154:4165-4172.
12. 2-terminal residue converts monocyte chemotactic protein 1 from an activator of basophil mediator release to an eosinophil chemoattractant J Exp Med 1996, 183:681-685. This report describes amino-terminal processing of chemokines and the differential biological effects on basophils and eosinophils.
13. Power CA, Meyer A, Nemeth K, Bacon KB, Hoogewerf AJ, Proudfoot AEI, Wells TNC: Molecular cloning and functional expression of a novel CC chemokine receptor cDNA from a human basophilic cell line. J Biol Chem 1995, 270:19495-19500.
14. Bacon KB, Premack BA, Gardner P, Schall TJ : Activation of dual T cell signaling pathways by the chemokine RANTES. Science 1995, 269:1727-1730. A single chemokine can activate a T cell through both G protein pathways and protein tyrosine kirase pathways.
15. Kuna P, Reddigari SR, Rucinski D, Schall TJ, Kaplan AP: Chemokines of the α, β-subclass inhibit human basophils responsiveness to monocyte chemotactic and activating factor/monocyte chemoattractant protein-1. J Allergy Clin Immunol 1995, 95:574-586.
16. Hartmann K, Beiglbock F, Czametzki BM, Zuberbier T: Effect of CC chemokines on mediator release from human skin mast cells and basophils. Int Arch Allergy Immunol 1995, 108:224-230.
17. Okayama Y, Brzezinska-Blaszczyk E, Kuna P, Kaplan AP,-Church MK: Effects of PBMC-derived histamine releasing factors on histamine release from human skin and lung mast cells. Clin Exp Allergy 1995, 25:890-095.
18. Fureder W, Agis H, Semper H, Keil F, Maier U, Muller MR, Czerwenka K, Hofler H, Lechner K, Valent P: Differential response of human basophils and mast cells to recombinant chemokines. Ann Hematol 1995, 70:251-258. This paper clearly shows that a wide spectrum of chemokines activates basophils with essentially no effect an human mast cells from a variety of sources.
19. Sarmiento EU, Espiritu BR, Gleich GJ, Thomas LL: IL-3, IL-5 and granulocyte-macrophage colony-stimulating factor potentiate basophil mediator release stimulated by eosinophil granule major basic protein. J Immunol 1995, 155:2211-2221. This paper shows the effect of an eosinophii granule product on human basophils. It also describes the presence of a large number of IL-3 receptors on human basophils.
20. +. J Immunol 1995, 155:2652-2660.
21. Columbo M, Horowitz EM, Kagey-Sobotka A, Lichtenstein LM: Histamine release from human basophils induced by platelet activating factor: the role of extracellular calcium, interleukin-3, and granulocyte-macrophage colony-stimulating factor. J Allergy Clin Immunol 1995, 95:565-573.
22. Yamaguchi M, Hirai K, Ohta K, Suzjki K, Kitani S, Takaishi T, Ito K, Ra C, Marita Y: Nonreleasing basophils convert to releasing basophils by culturing with IL-3. J Allergy Clin Immunol 1996, 97:1279-1287. A very interesting paper describing the effect of IL-3 on the ability of human basophils to release histamine. The data suggest that culturing basophils with IL-3 alters an early signal transduction event that is distal to FcεRI.
23. Van Gils FC, Van Teeffelen ME, Neelis KJ, Hendrix J, Burger H, Van Leen RW, Knol E, Wagemaker G, Wognum AW: lnterleukin-3 treatment of rhesus monkeys leads to increased production of histamlne-releasing cells that express interleukin-3 receptors at high levels. Blood 1995, 86:592-597.
24. MacDonald SM, Rafnar T, Langdon J, Lichtenstein LM: Molecular identification of an IgE-dependent histamine-releasing factor. Science 1995, 269:688-690. The subcloning of a novel HRF.
25. Schroeder JT, Kagey-Sobotka A, MacGlashan DW, Lichtenstein LM: The interaction of cytokines with human basophils and mast cells. Int Arch Allergy Immunol 1985, 107:79-81.
26. Ochensberger B, Rihs S, Brunner T, Dahinden CA: IgE-independent interleukin-4 expression and induction of a late phase of leukotriene C4 formation in human blood basophils. Blood 1995, 86:4039-4049.
27. Li H, Sim TC, Alam R: IL-13 released by and localized in human basophils. J Immunol 1996, 156:4833-4838. The first report that human basophils secrete IL-13.
28. Schroeder JT, Lichtenstein LM, MacDonald SM: An immunoglobulin E-dependent recombinant hislamine-releasing factor induces interleukin-4 secretion from human basophils. J Exp Med 1996, 183:1265-1270. A correlation is shown between the amount of histamine released and IL-4 protein produced when human basophils are stimulated with the rHRF.
29. Seminario M-C, Gleich GJ: The role of eosinophils in the pathogenesis of asthma. Curr Opin Immunol 1994, 6:860-864.
30. Alam R, York J, Boyars M, Stafford S, Grant JA, Lee J, Forsythe P Sim T, Ida N: Increased MCP-1, RANTES. and MIP-lα in bronchoalveolar lavage fluid of allergic asthmatic patients. Am J Respir Crit Care Med 1996, 163:1398-1404.
31. Sim TC, Reece LM, Hilsmeier KA, Grant JA, Alam R: Secretion of chemokines and other cytokines in allergen-induced nasal responses: inhibition by topical steroid treatment Am J Respir Crit Care Med 1995, 152:927-933.
32. Cruikshank WW, Long A, Tarpy RE, Kornfeld H, Carroll MP, Teran L. Holgate ST, Center DM: Early identification of interleukin-16 (lymphocyte chemoattractant factor) and macrophage inflammatory protein 1α (MIP1α) in bronchoalveolar lavage fluid of antigen-challenged asthmatics. Am J Respir Cell Mol Biol 1995, 13:738-747
33. Sampson HA, Broadbent KR, Bernhisel Broadbent J: "Spontaneous" basophil histamine release and histamine releasing factor in patients with atopic dermatitis and food hypersensitivity. N Engl J Med 1989, 321:229-232.
34. Langdon J, Anders K, Lichtanstein LM, MacDonald SM: Atopics translate mRNA for the IgE-dependent histamine releasing factor (HRF) more effectively than normal. J Allergy Clin Immunol Abstr 1995, 95:336.